DataMeds AI (MEDS) Receivables (2024 - 2026)

DataMeds AI (MEDS) has reported Receivables for 3 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 61.12% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 61.12% YoY), and the FY2025 full-year result was $2.5 million, down 47.15% from the prior year.
• Receivables retreated to $1.9 million in Q1 2026 per MEDS's latest filing, from $2.5 million in the prior quarter.
• Across five years, Receivables topped out at $5.0 million in Q1 2025 and bottomed at $1.9 million in Q1 2026.
• Historically, Receivables has averaged $3.6 million across 3 years, with a median of $3.7 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Receivables plunged 47.15% in 2025, then tumbled 61.12% in 2026.
• Over 3 years, Receivables stood at $4.7 million in 2024, then sank by 47.15% to $2.5 million in 2025, then fell by 21.77% to $1.9 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $1.9 million, $2.5 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.